On August 25, 2020 OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, reported that Daniel J. O’Connor, President and Chief Executive Officer will present at the LD 500 Virtual Conference on Wednesday, September 2, 2020 (Press release, OncoSec Medical, AUG 25, 2020, View Source/press-releases/detail/2060/oncosec-to-present-at-the-ld-500-virtual-conference-on" target="_blank" title="View Source/press-releases/detail/2060/oncosec-to-present-at-the-ld-500-virtual-conference-on" rel="nofollow">View Source [SID1234564000]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will begin September 2, 2020 at 10:00 a.m. eastern time, Track 3, followed by a live Q&A session with registered investors and other conference attendees. The OncoSec presentation will be webcast at View Source, and will be available on the Investors section of OncoSec’s website, View Source, where it will be archived for approximately 30 days.

The virtual conference and presentations will be held via webcast from September 1 – 4, 2020 and Mr. O’Connor will be available for virtual one-on-one meetings throughout. To schedule a meeting, please contact Eric Lahiji at [email protected].